LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTLicense, Development and Commercialization Agreement • February 7th, 2019 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
This License, Development and Commercialization Agreement (this “Agreement”), dated as of October 31, 2018 (the “Effective Date”), is made by and between MEI Pharma, Inc., a Delaware corporation having an office at 3611 Valley Centre Drive STE 500, San Diego, CA 92130 (“MEI”), and Kyowa Hakko Kirin Co., Ltd., a Japanese corporation having an office at 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan (“KHK”). MEI and KHK are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
